Medtronic will carve out its patient monitoring and respiratory interventions businesses, which are part of its broader medical surgical portfolio, the company announced on 24 October.
“We are executing on our portfolio management strategy, taking action to create value for Medtronic and our shareholders,” Medtronic CEO Geoff Martha said. The company told investors in early 2022 that it was considering divestitures consistent with the new operating model that Martha installed in 2020
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?